000 01161 a2200301 4500
005 20250515013615.0
264 0 _c20060407
008 200604s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD004197.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWood, D M
245 0 0 _aAntibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cJan 2006
300 _aCD004197 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aHumans
650 0 4 _aPseudomonas Infections
_xdrug therapy
650 0 4 _aPseudomonas aeruginosa
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTobramycin
_xtherapeutic use
700 1 _aSmyth, A R
773 0 _tThe Cochrane database of systematic reviews
_gno. 1
_gp. CD004197
856 4 0 _uhttps://doi.org/10.1002/14651858.CD004197.pub2
_zAvailable from publisher's website
999 _c16052020
_d16052020